文献速递多重用药衰弱、肌少症与跌倒

药物审查与deprescribing对长期护理机构老年人处方适宜性及临床结局影响的系统综述与荟萃分析

Evaluating the impact of medication review and deprescribing on prescribing appropriateness and clinical outcomes in older people residing in long-term care facilities: a systematic review and meta-analysis.
PubMed 文献 · Age Ageing · 2026-01-01

该系统综述与荟萃分析纳入38项研究(22项RCT、16项准实验研究),评估药物审查/deprescribing干预对长期护理机构多重用药老年人的影响。汇总分析显示干预可显著减少每人用药数量及潜在不适当用药(PIMs),但对跌倒、住院或死亡率无显著影响。研究存在较大方法学异质性,偏倚风险为中至高度。

要点

  • 药物审查/deprescribing可显著减少长期护理机构多重用药老年人的用药数量及PIMs。
  • 干预对跌倒、住院或死亡率无显著影响。
  • 纳入研究异质性大,偏倚风险以中高度为主,需更高质量标准化研究。

核心结论

  • 综合性药物审查干预改善了长期护理机构多重用药老年人的处方适宜性,但未显著影响跌倒、住院和死亡率等临床结局。

研究设计与样本

  • 系统综述与荟萃分析,遵循PRISMA指南(PROSPERO: CRD42023486056),检索PubMed、Embase和Scopus截至2024年8月27日。
  • 纳入38项实验性研究(22项RCT、16项准实验研究),对象为长期护理机构中多重用药的老年居民。
  • 采用RoB 2评估RCT质量,ROBINS-I评估非随机研究质量。

主要发现

  • 12个月内每人用药数量减少-0.89(95% CI -1.46, -0.32),≥12个月减少-1.60(95% CI -2.68, -0.52)。
  • 6个月时PIMs减少-0.48(95% CI -0.74, -0.22),≥12个月减少-0.26(95% CI -0.40, -0.13)。
  • 跌倒、住院或死亡率均无显著效应。
  • 研究间方法学异质性大,偏倚风险为23项中等、14项高、1项低。

临床怎么用

  • 对长期护理机构多重用药老年人可考虑实施综合性药物审查与deprescribing以改善处方适宜性。
  • 应认识到现有证据未显示该干预能显著减少跌倒、住院或死亡,临床决策需综合评估。

局限性

  • 纳入研究存在宽泛的方法学异质性。
  • 多数研究偏倚风险为中至高度(23项中等、14项高、1项低)。
  • 需要进一步高质量、标准化方法的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Polypharmacy is a major concern among older adults in long-term care facilities (LTCFs), as it increases the risk of potentially inappropriate medications (PIMs) and related adverse outcomes. Medication review and deprescribing interventions may help optimise therapy and reduce harm. DESIGN: Systematic review and meta-analysis. METHODS: This study was conducted according to PRISMA guidelines (PROSPERO: CRD42023486056). PubMed, Embase and Scopus were searched up to 27 August 2024, for experimental studies evaluating the impact of medication review/deprescribing interventions in older LTCF residents with polypharmacy. Outcomes included medication appropriateness indexes, falls, hospitalisations and mortality. We calculated risk ratios for dichotomous data and mean differences for continuous data [with 95% confidence intervals (CIs)]. The quality of the studies was assessed using RoB 2 for the randomised controlled trials (RCTs) and the ROBINS-I for non-randomised studies. RESULTS: From 3548 records, 38 studies (22 RCTs, 16 quasi-experimental) were included. Pooled analyses demonstrated significant reductions in the number of drugs per patient [within 12 months: -0.89 (95% CI -1.46, -0.32); at ≥12 months: -1.60 (95% CI -2.68, -0.52)] and in PIMs [at 6 months: -0.48 (95% CI -0.74, -0.22); at ≥12 months: -0.26 (95% CI -0.40, -0.13)]. No significant effects were observed on falls, hospitalisations or mortality. Studies showed wide methodological heterogeneity and had moderate to high risk of bias (23 moderate, 14 high, 1 low). CONCLUSIONS: Comprehensive medication review interventions improved prescribing appropriateness in older LTCF residents with polypharmacy but did not significantly affect clinical outcomes (i.e. falls, hospitalisations and mortality). Further high-quality studies using standardised approaches are needed.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Carollo M, Cristini I, Crisafulli S, et al. Evaluating the impact of medication review and deprescribing on prescribing appropriateness and clinical outcomes in older people residing in long-term care facilities: a systematic review and meta-analysis. Age Ageing. 2026. PMID: 41967033. doi:10.1093/ageing/afag084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。